Recent studies have shown that mesangial cells derived from human adult glomeruli synthesize a number of 35S-labelled proteoglycans including a large chondroitin sulphate proteoglycan (CSPG), two dermatan sulphate proteoglycans (biglycan and decorin) and two heparan sulphate proteoglycans [Thomas, Mason and Davies (1991) Biochem. J. 277, 81-88]. In the present study we have examined the interaction of these proteoglycans with hyaluronan (HA) using associative gel chromatography. Only the large CSPG bound to HA, with 60 % of those molecules in the medium and 80 % of those in the cell layer being able to interact. Reduction and alkylation, or treatment of the monomer CSPG with proteinases, prevented the formation of aggregates, suggesting. that the core protein was involved. The aggregates formed between purified CSPG and HA could be dissociated in the presence of HA-oligosaccharides of at least 10 monosaccharides in length. The inclusion of link protein with CSPG
INTRODUCTION
The glomerular mesangial cell is surrounded by a pericellular matrix the composition of which helps to determine the physical, mechanical and functional properties of the glomerulus. This matrix is composed mainly of type-IV collagen together with varying amounts of fibronectin, laminin and proteoglycans [1, 2] . Histochemical and immunohistochemical studies indicate that proteoglycans of both heparan sulphate and chondroitin sulphate/dermatan sulphate varieties are present [3] [4] [5] [6] . Cultures of adult human mesangial cells synthesize a large chondroitin sulphate proteoglycan (CSPG), situated mainly in the cell layer, and small dermatan sulphate proteoglycans (DSPGs), which are found almost exclusively in the culture medium [7] . The DSPGs were identified as PG-I (biglycan) and PG-Il (decorin), with the former molecule accounting for the majority of these species of proteoglycan. The mesangial-cell CSPG was not fully characterized but had some properties which were similar to the large CSPGs synthesized by vascular smooth-muscle cells, aortic endothelial cells and fibroblasts [8] [9] [10] [11] [12] . These molecules belong to a family of proteoglycans related functionally to the aggregating CSPG ofcartilage (aggrecan), as they are all capable of interacting with hyaluronan (HA) to form proteoglycan-HA aggregates.
HA is a critical component of most extracellular matrices and there is evidence that its physical and chemical properties not only participate in the maintenance of organized structures but and HA promoted the formation of aggregates. Experiments with 3H-labelled mesangial-cell proteoglycans confirmed that only the large CSPG, with core protein molecular masses of 400 kDa and 500 kDa, interacted with HA. After chondroitin ABC lyase treatment of CSPG isolated from conditioned culture medium, several bands similar to those observed with 3H-labelled core proteins were identified using a polyclonal antiserum that recognizes versican. A monoclonal antibody recognizing the 1-C-6 epitope in the GI and G2 globular regions of aggrecan did not recognize either mesangial-cell CSPG or bovine aortic versican. Northern-blot analysis confirmed that human mesangial cells express versican. Thus human mesangial large CSPG is a member of the versican family of proteoglycans. The interaction of CSPG and HA within the glomerulus may be important in glomerular cell migration and proliferation. also regulate cell migration, adhesion and proliferation (for a review see ref. [13] ). A role for HA in the function of the normal glomerulus has not been fully explored. It has been reported that mesangial cells derived from rat kidney synthesize HA [14] and a recent report indicated the presence of an HA-binding receptor in kidney tissue, which appears to be located on the plasma membrane and may provide a mechanism by which HA interacts with the surfaces of glomerular cells [15] . A second possible role for HA within the mesangium could involve the interaction with the large CSPGs known to be synthesized by mesangial cells [7, 14] . The present investigation shows that the CSPGs do interact with HA and provides immunochemical evidence that they are related to the versican family of proteoglycans.
MATERIALS AND METHODS
Cell culture Human mesangial cells were cultured and characterized by methods previously reported by us [7] . All [16] . To 
Extraction and isolation of proteoglycans
After incubation with radiolabelled precursors the proteoglycans in the culture medium and cell layer were extracted in the presence of proteinase inhibitors, as described previously [16] . To recover the total proteoglycan population the culture medium and cell layer were buffer-exchanged on a Sephadex G-50 column ( [7, 16] . A 4 M guanidine hydrochloride extract was prepared from 20 ,uM sections of normal human articular cartilage from a 31-year-old patient [17] . Pig laryngeal cartilage aggrecan (AID1) was prepared according to the method of Hardingham et al. [18] . An authentic sample ofbovine aortic versican was kindly donated by Professor D. Heinegard (University of Lund, Lund, Sweden) [19] .
Gel chromatography of proteoglycans
Proteoglycans were subjected to analytical gel-permeation chromatography at room temperature on a column (6 mm x 1.5 m) of Sepharose CL-2B or CL-4B equilibrated and eluted with either 4 M guanidine hydrochloride, 50 mM sodium acetate, pH 6.0, containing 0.5 % Triton X-100 (dissociative buffer), or 0.5 M guanidine hydrochloride, 0.1 M Tris/HCl, pH 7.0, 0.5 % CHAPS (associative buffer).
Characterization of newly synthesized HA The [3H]HA pool eluted from the Mono Q column described above was applied to a column (2 cm x 15 cm) of Sephadex G-50 equilibrated in 50 mM NH4HCO3. The material eluting in the void volume was freeze-dried, taken up in 0.1 M sodium acetate buffer, pH 6.0, containing papain (3 ,ug/ml) but no cysteine or EDTA [20] and digested at 60°C for 16 h. After incubation the material was passed over a Sephacryl S-500 column equilibrated in dissociative buffer and analysed for radioactivity.
Proteoglycan-HA-binding experiments
The ability of mesangial-cell CSPG to form aggregates with HA was assessed by analysing the shift in the elution from the included volume to the excluded volume of an associative Sepharose CL-2B column after interaction with the glycosaminoglycan. Preparations of total 35S-labelled proteoglycans from culture medium or the cell layer, or samples of individually purified 35S-labelled proteoglycans were incubated with HA (1 mg/ml, human umbilical; Sigma) and then dialysed extensively against associative buffer. After dialysis the mixture was chromatographed on an associative Sepharose CL-2B column.
In other experiments the ability of mesangial-cell CSPG to form aggregates with HA was compared with that ofpig laryngeal cartilage aggrecan. Aggrecan and link protein were isolated as described previously [21] and dissolved in 4 [24, 25] . CSPGs were digested with chondroitin ABC lyase [26] in the presence of proteinase inhibitors, as described by Oike et al. [27] . Mesangial-cell CSPG was reduced with 5 mM dithiothreitol for 5 h at 45°C and alkylated by incubation overnight at 4 'C in the dark with 35 mM iodoacetamide.
SOS/PAGE and Western-blot analysis
Electrophoresis was performed on either 3-12 % or 5-15 % (with a 4 % stacking gel) polyacrylamide gradient gels using the buffer system of Laemmli [28] . Samples for Western-blot analysis were purified from the conditioned culture medium ofconfluent human mesangial cells and stored with proteinase inhibitors [7] . Samples were digested with chondroitin ABC lyase (proteinase-free; ICN Biochemicals) (at 37°C for 4 h) and in some experiments with a combination of chondroitin ABC lyase and keratanase (proteinase-free; ICN Biochemicals). After digestion the products were separated by electrophoresis and transferred to Immobolin-P (Millipore, U.K.) and probed with rabbit anti-(bovine versican) serum (kindly provided by Professor D. Heinegard, Lund, Sweden), monoclonal antibody (mAb) 1-C-6, mAb 2B6 and mAb 3B3. The versican antiserum was raised against a large CSPG isolated from bovine aorta and does not cross-react with aggrecan isolated from bovine cartilage and sclera [19] . mAb 1-C-6 recognizes an epitope which is present on both globular regions of aggrecan [29] . For the detection of this epitope
Immobilin blots were reduced with 10 mM dithiothreitol. mAb 2B6 and mAb 3B3 recognize the unsaturated 4-and 6-sulphated disaccharides remaining after digestion of CSPGs with chondroitin ABC lyase [5] . Proteins were visualized using enhanced chemiluminescence (ECL) (Amersham International). For fluorography the fractions containing proteoglycans labelled with [3H]leucine (see the Results section) were pooled, dialysed against distilled water and freeze-dried. The labelled proteoglycans were then incubated with chondroitin ABC lyase and submitted to SDS/PAGE in a 3-12% (w/v) polyacrylamide gradient gel. The gels were impregnated with Amplify (Amersham), dried under vacuum and the labelled proteins were visualized by fluorography.
RNA Isolation and Northern-blot analysis
Total RNA from fifth passage human mesangial cells was isolated by a rapid RNA extraction protocol [30] . After quantification total RNA (10 ,g) was separated for 12 h in a formaldehyde/ MOPS/ 1.2 % agarose gel by standard techniques and transferred to a nylon membrane (NEN). Membranes were hybridized with a random-primed 32P-labelled human versican cDNA (Bioquote Ltd., York, U.K.) [31, 32] in standard formaldehyde conditions. This probe was derived from human IMR-90 lung fibroblasts and encodes for nucleic acids 1475-2802 plus the entire 3'-untranslated region. The membranes were also hybridized with a labelled human decorin cDNA (a kind gift from Dr. Larry To confirm these results, the large CSPG, decorin, biglycan, HSPG-I and HSPG-II synthesized by human mesangial cells in vitro were purified by ion-exchange and gel-filtration chromatography before and after selective degradation of the glycosaminoglycan side chains as described previously {see Figures 1(a) Figure 2 indicate that about 60 % of the 35S-labelled large CSPGs formed aggregates with HA. When the CSPGs which were not interacting were separated and re-incubated with HA they still eluted in the included volume of the CL-2B column (results not shown). In comparable experiments with large CSPG isolated from the cell layer, 80% bound to HA. The addition of decasaccharides (Figure 3a ) or higher-molecular-mass oligomers (results not shown) resulted in a significant reduction in the amount of 35S-CSPG eluting in the void volume. In contrast the incubation of HA/proteoglycan aggregates with octasaccharides or smaller oligomers had no effect on the elution profile (results not shown).
To investigate the specificity of mesangial-cell proteoglycan-HA interaction we prepared aggregating CSPG as described in Figure 2 . The aggregates were pooled and passed over a dissociative CL-2B column to separate the HA from the monomer CSPG. The interaction of this purified CSPG population with HA was abolished by prior digestion with papain or trypsin, indicating that the core protein was involved in some way. The importance of the core protein was emphasized further by experiments which demonstrated that reduction and alkylation of the purified aggregating CSPG before incubation with HA significantly reduced its ability to form aggregates (Figure 3b) .
In further experiments the ability of CSPG to interact with HA was compared with the same interaction with pig cartilage aggrecan. Aggrecan and 35S-labelled mesangial-cell CSPG together were dialysed to associative conditions and chromatographed on an associative Sepharose CL-2B column as described in the Materials and methods section. The CSPG has an overall smaller hydrodynamic size than aggrecan (Figure 4a ). When limiting amounts (200 #4g/ml) of HA were added before dialysis both proteoglycans showed some shift towards the excluded volume of the column in subsequent associative Sepharose CL-2B chromatography (Figure 4b ). However, when both HA and link protein were added before dialysis, both proteoglycans elute predominantly in the excluded volume (Figure 4c ). These results indicate that the CSPG can be incorporated into mixed proteoglycan-HA aggregates stabilized by link protein.
Characterization of the mesangpi-cell CSPG
To investigate the nature of the core protein of the mesangial-cell CSPG, fractions were pooled as indicated in Figure l(c) , dialysed, Aggregating mesangial-cell CSPGs were prepared as indicated in Figure 2 and (a) incubated with HA (0.2 mg/ml) in the presence (0) and absence (@) of HA decasaccharide (2.5 mg/ml) and chromatographed on an associative CL-2B column; (b) CSPG-HA aggregates (see Figure  2 ) were pooled and passed over a dissociative CL-2B column to separate HA from monomer CSPG. Aliquots of the monomer in dissociative buffer were either incubated alone or reduced and alkylated, dialysed into associative buffer and then reincubated with HA (0.2 mg/ml). The mixture containing the non-reduced (0) and reduced (0) CSPG was chromatographed on an associative Sepharose CL-2B column.
digested with chondroitin ABC lyase and the products examined by SDS/PAGE under reducing conditions followed by fluorography. The results are shown in Figure 5 . Pool 1 contained a large CSPG which yielded two major core proteins with apparent molecular masses of 500 and 400 kDa and a minor band at 350 kDa (lane 1). These bands were not present in control incubations without chondroitin ABC lyase present (results not shown). Thus the pool I proteoglycan corresponds to the mesangial-cell large CSPG previously described by us, which was shown to have similar core protein heterogeneity [7] . Similar treatment of the proteoglycans in pool 2 failed to yield the 500 kDa protein but did show a clear band at 400 kDa together with some minor bands of lower molecular mass ( Figure 5 , lane 2). Treatment of the third pool of proteoglycans with chondroitin ABC lyase resulted in the appearance of core proteins with molecular masses consistent with decorin and biglycan ( Figure 5 ,
Western-blot and Northern-blot analysis of mesangial-cell CSPG Two large CSPGs have been identified in the tissue, which interact with HA. These are aggrecan, the major proteoglycan of hyaline cartilage [34, 35] , and versican [32] , which was isolated from a number of tissues as described above. To investigate the K,V. to reveal three major bands ( Figure 6 , lane 1) in the same molecular mass range as detected by metabolic labelling with [3H]leucine ( Figure 5 ). After allowing time for all the ECL activity on the Immobolin to decay, it was reprobed with either mAb 2B6 or 3B3. These experiments showed that the bands which reacted with the versican antiserum contained both 4-and 6-sulphated linkage region disaccharides ( Figure 6 , lanes 3 and 4). These mAbs also detected lower-molecular-mass components corresponding to biglycan and probably decorin, which are present in the medium of human mesangial-cell cultures [7] . In a separate experiment the mesangial-cell CSPGs, human cartilage proteoglycans and bovine versican were probed with the antiversican serum and mAb I-C-6. All lanes were intentionally overloaded. All these proteoglycan preparations reacted with the anti-versican serum ( Figure 6, lanes 5-7) . This indicates the presence of versican-like proteoglycans in adult human articular cartilage. Neither the mesangial-cell CSPG or bovine versican reacted with mAb l-C-6 ( Figure 6, lanes 8-10) . We next confirmed, by carrying out Northern-blot analysis for mRNA, that human mesangial cells expressed versican. Hybridization of membranes with cDNA probes for versican and decorin revealed mRNA species of 8.2, 1.9 and 1.6 kb ( Figure 7) . The large species correspond to the mRNA for versican [32] and the smaller species to mRNA for decorin [33] . In parallel experiments we failed to detect mRNA for aggrecan core protein.
Synthesis of HA by mesangial cells
In view of the above interaction between CSPG and HA we investigated HA synthesis by human adult mesangial cells. Cells Figure 7 Northern-blot analysis of human mesangial-cell proteoglycans Total RNA was purified from confluent human mesangial cells and analysed by Northern-blot analysis. Specific mRNAs were hybridized with cDNA probes for versican (arrowhead) and decorin (arrows) (see Materials and methods section).
were incubated with [3H]glucosamine and the labelled material in the cell layer and the culture medium was buffer-exchanged and subjected to ion-exchange chromatography on a Mono Q column as described in the Materials and methods section. The HA pool was digested with papain and analysed by gel chromatography on Sephacryl S-500 (Figure 8 
DISCUSSION
In a previous study we demonstrated that adult human mesangial cells in culture synthesize two DSPGs, biglycan and decorin, a large CSPG and two heparan sulphate proteoglycans. The CSPG was not positively identified but after chondroitin ABC lyase treatment of 1251-labelled molecules protein cores of 500 kDa and 400 kDa were obtained [7] . In the present study this heterogeneity was confirmed after metabolically labelling cultures with [3H]leucine. In the final purification step for these experiments the CSPG was separated from other proteoglycans in the medium on the basis of its ability to form aggregates with HA. Two major 3H-labelled core proteins of molecular masses 400 and 500 kDa, together with a minor band at 350 kDa, were identified. Moreover when the partially purified proteoglycans from the culture medium were treated with the same lyase, electrophoresed, blotted and probed with a polyclonal antibody raised against bovine versican [19] [32] . The appearance of the single band indicates that it is unlikely that major alternatively spliced messages for this molecule are processed. It is interesting, however, to note that cDNA analysis of PG-M, a large CSPG with high sequence similarity to versican revealed spliced multiforms [36] . PG-M also showed core-protein heterogeneity.
The large CSPGs were capable of interacting under associative conditions with HA to form large aggregates. The specificity of this interaction was emphasized by several experiments. First, the interaction was specific for the type of proteoglycan, as neither dermatan sulphate nor heparan sulphate proteoglycans formed complexes. Secondly, the interaction was mediated via a domain in the core protein, since trypsin treatment of monomer proteoglycan in the presence or absence of HA prevented the formation of aggregates. Thirdly, the CSPG monomer could be displaced readily from the aggregates by the addition of decasaccharides or larger oligomers of HA [35, 37] .
Reports in the literature have indicated the existence of structural heterogeneity among large CSPGs extracted from several different tissues and from cells in vitro [8, 9, 11, 19, 36, 38] . This heterogeneity may reflect their biological properties, as those from bovine and pig aorta were subfractionated according to their binding capacity to low-density lipoproteins [39] and their ability to bind antithrombin III [40] respectively. Using associative CsCl centrifugation, Morita et al. [12] separated two populations of large CSPGs from the conditioned medium of cultured mouse aortic endothelial cells based on their ability to form aggregates with HA. Furthermore although the protein cores of proteoglycans secreted into the medium and those isolated from the cells appeared to be polydisperse, only those with an apparent molecular mass of 550 kDa appeared to bind to HA. In the present study we also demonstrated similar coreprotein heterogeneity but in contrast with the endothelial-cellderived molecules the mesangial-cell species that bind HA consist of proteoglycans with both 500 kDa and 400 kDa core proteins. Another possibility is that they are derived from other proteoglycans such as the large dermatan proteoglycan expressed in human fibroblasts [41] . This proteoglycan, which does not interact with HA to form aggregates, is composed of two unrelated core proteins of 460 and 300 kDa.
Two groups ofaggregating CSPGs have been described [38, 42] . The most studied is aggrecan, the principal proteoglycan of hyaline cartilage. This proteoglycan forms aggregates with HA through a highly specific, non-covalent interaction mediated via the GI domain located in the N-terminal region. With aggrecan each interaction is stabilized by a single link protein, which shows sequence similarity with G1. The second form of aggregating CSPG has been named versican [32] . This molecule is synthesized by human fibroblasts and aortic smooth-muscle cells. In addition the large CSPG of mouse aortic endothelial cells closely resembles versican [12] . The cDNA of fibroblast versican has been sequenced and comparison with that of aggrecan clearly indicates that it is a different gene product [31, 32] . An apparent difference is the presence in versican of two epidermal growth factor-like regions situated adjacent to the G3 region. These were not detected in chick or rat aggrecan cDNA, but the occurrence of a single epidermal growth factor-like domain has been reported in some cDNA clones for human aggrecan core protein [43] .
While the experiments of LeBaron and co-workers [42] and Morita and co-workers [12] showed that versican interacts with HA, they did not investigate whether the aggregates which were formed could be stabilized with link protein in a manner analogous to aggrecan. Our data indicates that mesangial-cell CSPG does not contain the 1-C-6 epitope present in the GI domain of aggrecan, the site of interaction with link protein.
Nevertheless experiments in which cartilage link protein was added to mixtures of CSPG and HA suggest that it promotes the stabilization of aggregates (see Figure 4c) .
Since the mesangial-cell-derived large CSPG is recognized by an antibody raised against bovine versican the immunological data strongly suggest that this large aggregating CSPG is related to versican rather than aggrecan. The presence, in our experiments, of mRNA for versican, but not aggrecan, in human mesangial cells supports this conclusion.
An unexpected finding in the present investigation was that the extracts of human adult articular cartilage contained protein that was recognized by anti-versican serum. This extends the recent observation of Grover and Roughley [44] , who demonstrated the presence of mRNA for versican in human chrondrocytes using PCR, and represents a novel location for the distribution for this proteoglycan.
Preliminary data suggest that a large CSPG may play an important role in mesangial-cell proliferation [45] . This finding is consistent with reports that show that CSPGs are expressed at a higher level in proliferating vascular smooth-muscle cells when compared with quiescent cells [46] . Moreover, HA is involved in a diverse array of biological processes, including cell differentiation, cell adhesion and proliferation [13] . Since mesangial cells synthesize HA the interaction of this molecule with CSPGs may be involved in the proliferation of these cells. However, additional studies are required to clarify the role of HA and HA-binding proteoglycans within the glomerulus. 
